Cureline provides access to the USA-based companies to Cytes Biotechnologies products based on human and animal liver cells and cell medium solutions for in vitro experiments.
Menu
Scientist.com is a combined public and private e-commerce marketplace for externalized research. It provides a platform for clients to find suppliers and research assistance services throughout all phases of clinical trial studies. Explore news articles about the Cureline Group on scientist.com.
Scienceexchange.com is a cloud-based marketplace that provides researchers, pharmaceutical companies and biotechnology companies with a platform for direct automated access to outsourced scientific products and services. Explore news articles about the Cureline Group on scienceexhange.com.
Cureline has formed strategic partnerships with industry leading providers, offering an integrated portfolio of standard and custom services for and development. Together with our partners we provide cost- and time-effective solution for:
The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) is a national effort to accelerate the understanding of the molecular basis of cancer through the application of large-scale proteome and genome analysis, or proteogenomics. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public.
Cellecta, Inc. was founded in April 2006 by one of the chief scientists from Clontech Laboratories. The company was borne out of the need for higher quality, more advanced shRNA and other lentiviral libraries. Our goal was to develop advanced high-throughput (HT) genetic screen technologies and their applications for the discovery and functional characterization of novel therapeutic targets and drugs.We offer a variety of off-the-shelf products and custom services that enable: highly customized research using advanced lentiviral technology, including custom and genome-wide pooled lentiviral shRNA, CRISPR, CRISPRa/i, and barcode libraries for any set of genes in any lentivector
The current products on the market are designed to keep donor organs/tissue biopsies/therapeutic cells preserved and viable for up to 24 hours, after which time they usually die. For keeping organs, tissues and cells in a viable state during storage/transport by plane, train and car, Aqix Ltd have developed a unique product, AQIX RS-I®, which gives up to 72 hours of storage/transport time for all types of human biopsied tissues (especially valuable for deliveries to international destinations). It can currently only be used for laboratory research purposes only. It is used in the storage and transport of cells and tissue biopsies and normothermic perfusion of tissues and non-transplantable, human donor organs for use in new drug design bioassay investigations.Advancement in Preserving Human Tissue Morphology and Gene Expression Profiling. We are glad to present you the most recent effort of our strategic partner AQIX® Fluid Technology.
Oncolead utilizes its expertise to work with large 100-400 cell line panels. We perform screening in selected cell panels, analyze the dose response parameters (e.g. IC/GI and slop values), link activity profile with cell mutation status, and further compare the profile of the candidate drug to the profiles of thousands known anticancer agents. Our standard 90+ cell line panel is the most cost effective and fastest approaches to characterize earlier stage anticancer agents. In addition, Oncolead provides complementary tests by using selected cell lines or even complete cell panels. We offer combination studies with more than 500 combination pairs, detection of drug tolerance, drug treatment for up to 4 weeks at diverse schedules, and cell cycle analysis. We focus our efforts on results interpretation and assist our customers with tailored data analysis and consulting.
Streck develops and manufactures products for clinical and research laboratories. Cell-Free DNA BCT® (streck.com/cell stabilization) is a 10 mL blood collection tube with a formaldehyde-free preservative that stabilizes white blood cells, preventing the release of genomic DNA, allowing isolation of high-quality cell-free DNA. Samples collected in Cell-Free DNA BCT are stable for up to 14 days at room temperature, allowing convenient sample collection, transport, and storage. For Research Use Only. Cell-Free DNA Urine Preserve (streck.com/cell stabilization) is a formaldehyde-free liquid reagent that stabilizes cfDNA in urine. Samples treated with Cell-Free DNA Urine Preserve are stable up to 7 days at 6 °C to 37 °C, allowing for convenient transportation and storage.
Cureline provides access to the USA-based companies to Cytes Biotechnologies products based on human and animal liver cells and cell medium solutions for in vitro experiments.
